Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy

Intraperitoneal (IP) chemotherapy has revived hopes during the past few years for the management of peritoneal disseminations of digestive and gynecological cancers. Nevertheless, a poor drug penetration is one key drawback of IP chemotherapy since peritoneal neoplasms are notoriously resistant to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamsi, Milad, Sedaghatkish, Amir, Dejam, Morteza, Saghafian, Mohsen, Mohammadi, Mehdi, Sanati-Nezhad, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011950/
https://www.ncbi.nlm.nih.gov/pubmed/29589479
http://dx.doi.org/10.1080/10717544.2018.1455764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011950/
https://www.ncbi.nlm.nih.gov/pubmed/29589479
http://dx.doi.org/10.1080/10717544.2018.1455764

Ejemplares similares